Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The three projects include work on an effective vaccine, enabling pre-clinical and clinical vaccine trials, as well as supporting researchers to develop manufacturing processes to produce a vaccine at a million-dose scale.

Another project will examine how existing treatments could be repurposed to treat coronavirus: Professor Sarah Gilbert, £2.2 million for vaccine development and trials; Professor Peter Horby - £2.1 million for research into the effectiveness of current drugs on COVID-19 and Dr Sandy Douglas – £0.4 million, research into vaccine manufacturing capabilities.

The full article is available from the University of Oxford's Website

Similar stories